Patient Safety Organizations: Voluntary Delisting, 63498-63499 [2010-25771]
Download as PDF
<![CDATA[
63498
Federal Register / Vol. 75, No. 199 / Friday, October 15, 2010 / Notices
Web site at https://www.ahrq.gov no later
than November 1, 2010.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: October 5, 2010.
Carolyn M. Clancy,
Director.
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Closed Meeting
[FR Doc. 2010–25774 Filed 10–14–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Congenital
Diaphragmatic Hernia.
Date: November 9, 2010.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Neelakanta Ravindranath,
PhD, Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01G, Bethesda, MD 20892,
301–435–6889, ravindrn@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 6, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–26029 Filed 10–14–10; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
16:01 Oct 14, 2010
Jkt 223001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Clinical Review of
R01s.
Date: October 26, 2010.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Hungyi Shau, Scientific
Review Officer, National Center for
Complementary and Alternative Medicine,
National Institutes of Health, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892, 301–402–1030,
Hungyi.Shau@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: October 5, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–26026 Filed 10–14–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Statistical Analysis in Support of DPMC
Clinical Trials (8894).
Date: October 27–28, 2010.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: October 6, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–26024 Filed 10–14–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Delisting
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of delisting.
AGENCY:
AHRQ has accepted a
notification of voluntary relinquishment
from the ACCE Healthcare Technology
Foundation of its status as a Patient
Safety Organization (PSO). The Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act), Public Law
109–41, 42 U.S.C. 299b–21–b–26,
provides for the formation of PSOs,
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety and Quality
Improvement Final Rule (Patient Safety
Rule), 42 CFR part 3, authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a PSO an entity that attests that it
meets the statutory and regulatory
SUMMARY:
E:\FR\FM\15OCN1.SGM
15OCN1
Federal Register / Vol. 75, No. 199 / Friday, October 15, 2010 / Notices
requirements for listing. A P80 can be
‘‘delisted’’ by the Secretary if it is found
to no longer meet the requirements of
the Patient Safety Act and Patient Safety
Rule, including when a P80 1 chooses
to voluntarily relinquish its status as a
PSO for any reason.
The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12 Midnight
ET(2400) on September 21, 2010.
DATES:
FOR FURTHER INFORMATION CONTACT:
Diane Cousins, RPh, Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toIl free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; E-mail:
pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
mstockstill on DSKH9S0YB1PROD with NOTICES
Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery. HHS issued the Patient Safety
Rule to implement the Patient Safety
Act. AHRQ administers the provisions
of the Patient Safety Act and Patient
Safety Rule (PDF file, 450 KB. PDF
Help) relating to the listing and
operation of PSOs. Section 3.108(d) of
the Patient Safety Rule requires AHRQ
to provide public notice when it
removes an organization from the list of
federally approved PSOs. AHRQ has
accepted a notification from the ACCE
Healthcare Technology Foundation,
PSO number P0017, to voluntarily
relinquish its status as a PSO.
Accordingly, the ACCE Healthcare
Technology Foundation was delisted
effective at 12:00 Midnight ET (2400) on
September 21, 2010.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.AHRQ.gov/
index.html.
BILLING CODE 4160–90–M
VerDate Mar<15>2010
16:01 Oct 14, 2010
Jkt 223001
Extension of Agency Information
Collection Activity Under OMB Review:
Sensitive Security Information Threat
Assessments
Transportation Security
Administration, DHS.
ACTION: 30 day notice.
Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.AHRQ.gov/.
[FR Doc. 2010–25771 Filed 10–14–10; 8:45 am]
Transportation Security Administration
AGENCY:
ADDRESSES:
Dated: October 1, 2010.
Carolyn M. Clancy,
Director.
DEPARTMENT OF HOMELAND
SECURITY
This notice announces that
the Transportation Security
Administration (TSA) has forwarded the
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0042,
abstracted below to OMB for review and
approval of an extension of the
currently approved collection under the
Paperwork Reduction Act (PRA). The
ICR describes the nature of the
information collection and its expected
burden. TSA published a Federal
Register notice, with a 60-day comment
period soliciting comments, of the
following collection of information on
July 30, 2010 75 FR 44974. The
collection involves TSA determining
whether the party or representative of a
party seeking access to sensitive
security information (SSI) in a civil
proceeding in Federal court may be
granted access to the SSI.
DATES: Send your comments by
November 15, 2010. A comment to OMB
is most effective if OMB receives it
within 30 days of publication.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, OMB. Comments should be
addressed to Desk Officer, Department
of Homeland Security/TSA, and sent via
electronic mail to
oira_submission@omb.eop.gov or faxed
to (202) 395–6974.
FOR FURTHER INFORMATION CONTACT:
Joanna Johnson, TSA PRA Officer,
Office of Information Technology (OIT),
TSA–11, Transportation Security
Administration, 601 South 12th Street,
Arlington, VA 20598–6011; telephone
(571) 227–3651; e-mail
TSAPRA@dhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. The ICR documentation is
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
63499
available at https://www.reginfo.gov.
Therefore, in preparation for OMB
review and approval of the following
information collection, TSA is soliciting
comments to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including using
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Information Collection Requirement
Title: Sensitive Security Information
Threat Assessments.
Type of Request: Extension of a
currently approved collection.
OMB Control Number: 1652–0042.
Forms(s): TSA 2211.
Affected Public: Individuals seeking
access to SSI Information.
Abstract: TSA has implemented
Section 525 of the DHS Appropriations
Act 1, 2007, Public Law 109–925, see
525(d) (October 4, 2006), as reenacted in
the Department of Homeland
Appropriations Act, 2008, Public Law
110–161, sec. 522 (Dec 26, 2007);
Department of Homeland Security
Appropriations, 2009, Public Law 110–
329, D.V.D. sec. 510 (September 30,
2008), and Department of Homeland
Security Appropriations Act 2010,
Public Law 111.83, sec. 510 (October 29,
2009), by establishing a process
whereby a party seeking access to SSI in
a civil proceeding in federal court that
demonstrates a substantial need for
relevant SSI in preparation of the party’s
case may request that the party
representative or court reporter be
granted access to the SSI. In order to
determine if the individual may be
granted access to SSI for this purpose,
TSA conducts a criminal history records
check (CHRC) and threat assessment.
Individuals are required to submit
information including identifying
information and an explanation
1 Department of Homeland Security
Appropriations Act, 2007, Pub. L. 109–925, see
525(d) (October 4, 2006), on reenacted in the
Department of Homeland Security Appropriations
Act, 2008, Public Law 110–161 Div. E. Sec. 522
(December 26, 2007); Department of Homeland
Security Appropriations Act, 2009, Public Law
110–329 D.V.D. sec. 510 (September 30, 2008), and
Department of Security Appropriations Act 2010,
Public Law 111.83, sec. 510 (October 29, 2009).
E:\FR\FM\15OCN1.SGM
15OCN1
]]>Agencies
[Federal Register Volume 75, Number 199 (Friday, October 15, 2010)]
[Notices]
[Pages 63498-63499]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-25771]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Delisting
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: AHRQ has accepted a notification of voluntary relinquishment
from the ACCE Healthcare Technology Foundation of its status as a
Patient Safety Organization (PSO). The Patient Safety and Quality
Improvement Act of 2005 (Patient Safety Act), Public Law 109-41, 42
U.S.C. 299b-21-b-26, provides for the formation of PSOs, which collect,
aggregate, and analyze confidential information regarding the quality
and safety of health care delivery. The Patient Safety and Quality
Improvement Final Rule (Patient Safety Rule), 42 CFR part 3, authorizes
AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity
that attests that it meets the statutory and regulatory
[[Page 63499]]
requirements for listing. A P80 can be ``delisted'' by the Secretary if
it is found to no longer meet the requirements of the Patient Safety
Act and Patient Safety Rule, including when a P80 1 chooses to
voluntarily relinquish its status as a PSO for any reason.
DATES: The directories for both listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. The delisting was effective at 12 Midnight
ET(2400) on September 21, 2010.
ADDRESSES: Both directories can be accessed electronically at the
following HHS Web site: https://www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT: Diane Cousins, RPh, Center for Quality
Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD
20850; Telephone (toIl free): (866) 403-3697; Telephone (local): (301)
427-1111; TTY (toll free): (866) 438-7231; TTY (local): (301) 427-1130;
E-mail: pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
is to conduct activities to improve patient safety and the quality of
health care delivery. HHS issued the Patient Safety Rule to implement
the Patient Safety Act. AHRQ administers the provisions of the Patient
Safety Act and Patient Safety Rule (PDF file, 450 KB. PDF Help)
relating to the listing and operation of PSOs. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of federally approved PSOs. AHRQ
has accepted a notification from the ACCE Healthcare Technology
Foundation, PSO number P0017, to voluntarily relinquish its status as a
PSO. Accordingly, the ACCE Healthcare Technology Foundation was
delisted effective at 12:00 Midnight ET (2400) on September 21, 2010.
More information on PSOs can be obtained through AHRQ's PSO Web
site at https://www.pso.AHRQ.gov/.
Dated: October 1, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-25771 Filed 10-14-10; 8:45 am]
BILLING CODE 4160-90-M
